Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05453396
Title Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

follicular lymphoma


Loncastuximab tesirine-lpyl

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.